Compound ID | 1451
Synonym(s): Zyvox
Class: Oxazolidinone
Spectrum of activity: | Gram-positive |
Details of activity: | MRSA and Streptococcus |
Institute where first reported: | Pfizer, USA |
Year first mentioned: | 1990 |
Highest developmental phase: | Approved by FDA in 2000 |
Development status: | Approved |
Chemical structure(s): | |
Canonical SMILES: | CC(=O)NC[C@H]1CN(C2=CC=C(C(=C2)F)N3CCOCC3)C(=O)O1 |
Isomeric SMILES: | CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F |
InChI: | InChI=1S/C16H20FN3O4/c1-11(21)18-9-13-10-20(16(22)24-13)12-2-3-15(14(17)8-12)19-4-6-23-7-5-19/h2-3,8,13H,4-7,9-10H2,1H3,(H,18,21)/t13-/m0/s1 |
InChI Key: | TYZROVQLWOKYKF-ZDUSSCGKSA-N |
Structure link: | https://pubchem.ncbi.nlm.nih.gov/compound/441401 |
External links: | |
Guide to Pharmacology: | linezolid |
Main Source: | https://link.springer.com/article/10.1007%2Fs40262-017-0601-x |